Merck & Co (MRK) revenue

Revenue · fiscal 2025
$65.01B

Merck & Co (MRK) reported revenue of $65.01B in fiscal 2025 (the year ended December 31, 2025). That is 1.3% higher than the $64.17B of fiscal 2024. Figures as of 18 Nov 2026, 09:26 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$65.01B
Change on fiscal 2024
+1.3%
Growth, 5 years
+9.4% a year
Growth, 10 years
+5.1% a year
Highest on record
$65.01Bfiscal 2025
Lowest on record
$23.85Bfiscal 2008
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Merck & Co revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 9.4% a year; over ten years the rate was 5.1% a year. Across the 19 fiscal years on record (2007–2025), the highest was $65.01B in fiscal 2025 and the lowest $23.85B in fiscal 2008.

History · 19 fiscal years

Revenue by fiscal year

Merck & Co revenue, year by year

Merck & Co (MRK) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$65.01B 1.3% up
2024$64.17B 6.7% up
2023$60.12B 1.4% up
2022$59.28B 21.7% up
2021$48.70B 17.3% up
2020$41.52B 6.1% up
2019$39.12B 7.5% down
2018$42.29B 5.4% up
2017$40.12B 0.8% up
2016$39.81B 0.8% up
2015$39.50B 6.5% down
2014$42.24B 4.1% down
2013$44.03B 6.8% down
2012$47.27B 1.6% down
2011$48.05B 4.5% up
2010$45.99B 67.7% up
2009$27.43B 15.0% up
2008$23.85B 1.4% down
2007$24.20B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Merck & Co and comparable companies
CompanyRevenueFiscal year
Johnson & Johnson JNJ$94.19B2025
AbbVie ABBV$61.16B2025
Merck & Co MRK$65.01B2025
UnitedHealth Group UNH$447.57B2025
Novartis NVS$56.67B2025
AstraZeneca AZN$58.74B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MRK

Merck & Co, figure by figure

Merck & Co (MRK) overview: price, valuation and scorecardAll health care companies by market value

Merck & Co revenue: questions and answers

What is Merck & Co's revenue?

Merck & Co (MRK) reported revenue of $65.01B in fiscal 2025 (the year ended December 31, 2025). That is 1.3% higher than the $64.17B of fiscal 2024.

What is the growth rate of Merck & Co's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 9.4% a year; over ten years the rate was 5.1% a year.

What are the highest and lowest revenue figures on record for Merck & Co?

Across the 19 fiscal years on record (2007–2025), the highest was $65.01B in fiscal 2025 and the lowest $23.85B in fiscal 2008.

How is Merck & Co's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Merck & Co it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Merck & Co (MRK) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/MRK/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.